Crypto.com has received regulatory approval to offer
margined derivatives trading on cryptocurrencies and other asset classes in the
United States.
The milestone follows an amendment to the company’s
designated contract market (DCM) license, enabling the cryptocurrency exchange
to hold a full suite of Commodity Futures Trading Commission (CFTC) derivatives
licenses.
Digital assets meet tradfi in London at the fmls25
Full CFTC Approval
The exchange’s U.S. affiliate, Crypto.com Derivatives
North America (CDNA), reportedly now holds all three key derivatives
permissions: futures commission merchant (FCM), designated contract market
(DCM), and derivatives clearing organization (DCO).
This means the platform can operate a derivatives
exchange, act as a clearinghouse, and intermediate trades, all under U.S.
regulatory oversight.
The CFTC granted CDNA the amended DCM license
alongside approvals for its DCO amendment and FCM registration on September 26,
2025.
Until now, CDNA has been limited in offering fully
collateralized derivatives through prediction markets. The new authorizations
expand its capabilities to include margined derivatives, including perpetual
contracts.
Regulatory Process
CDNA filed its request to amend the DCM order on May
31, 2024. As part of the approval process, it submitted extensive documentation
and conducted multiple trading demonstrations for CFTC staff review.
Crypto.com acquired a CFTC-registered exchange and
clearinghouse to strengthen its regulatory position in the U.S. derivatives
market. “Today marks a historic day for our company,” said Nick Lundgren, Chief
Legal Officer at Crypto.com.
With the amended licenses in place, CDNA plans to
introduce a suite of margined derivatives products in the coming months.
“CDNA has been building a robust exchange and
clearinghouse for multiple products, and we are excited to head to the launch of
our margined derivatives using state-of-the-art technology focused on
best-in-class risk management,” said Travis McGhee, Managing Director, Global
Head of Capital Markets of Crypto.com.
The company said it aims to integrate these products
into its existing platform, which also offers spot trading, prediction markets,
custody services, and other financial products. Product availability will
remain subject to jurisdictional approvals and regulatory requirements.
Crypto.com has received regulatory approval to offer
margined derivatives trading on cryptocurrencies and other asset classes in the
United States.
The milestone follows an amendment to the company’s
designated contract market (DCM) license, enabling the cryptocurrency exchange
to hold a full suite of Commodity Futures Trading Commission (CFTC) derivatives
licenses.
Digital assets meet tradfi in London at the fmls25
Full CFTC Approval
The exchange’s U.S. affiliate, Crypto.com Derivatives
North America (CDNA), reportedly now holds all three key derivatives
permissions: futures commission merchant (FCM), designated contract market
(DCM), and derivatives clearing organization (DCO).
This means the platform can operate a derivatives
exchange, act as a clearinghouse, and intermediate trades, all under U.S.
regulatory oversight.
The CFTC granted CDNA the amended DCM license
alongside approvals for its DCO amendment and FCM registration on September 26,
2025.
Until now, CDNA has been limited in offering fully
collateralized derivatives through prediction markets. The new authorizations
expand its capabilities to include margined derivatives, including perpetual
contracts.
Regulatory Process
CDNA filed its request to amend the DCM order on May
31, 2024. As part of the approval process, it submitted extensive documentation
and conducted multiple trading demonstrations for CFTC staff review.
Crypto.com acquired a CFTC-registered exchange and
clearinghouse to strengthen its regulatory position in the U.S. derivatives
market. “Today marks a historic day for our company,” said Nick Lundgren, Chief
Legal Officer at Crypto.com.
With the amended licenses in place, CDNA plans to
introduce a suite of margined derivatives products in the coming months.
“CDNA has been building a robust exchange and
clearinghouse for multiple products, and we are excited to head to the launch of
our margined derivatives using state-of-the-art technology focused on
best-in-class risk management,” said Travis McGhee, Managing Director, Global
Head of Capital Markets of Crypto.com.
The company said it aims to integrate these products
into its existing platform, which also offers spot trading, prediction markets,
custody services, and other financial products. Product availability will
remain subject to jurisdictional approvals and regulatory requirements.